Robin Kleiman
About Robin Kleiman
Robin Kleiman is the Vice President of CNS Biology at Alkermes, with extensive experience in neuroscience research and drug discovery.
Title
Robin Kleiman holds the title of Vice President, CNS Biology at Alkermes, located in Waltham, Massachusetts, United States. This role leverages his expertise in neuroscience, particularly in central nervous system biology.
Career at Biogen
Robin Kleiman worked at Biogen from 2017 to 2022. Initially, he was the Senior Director of Translational Cellular Sciences in the Greater Boston Area, a role he held for three years. From 2020 to 2022, he served as the Executive Director of Human Cell and Molecular Biology, leading initiatives in human cellular research with a focus on translational science.
Academic Roles at Harvard Medical School
Robin Kleiman was associated with Harvard Medical School from 2013 to 2017. He started as an Instructor of Neurology, a position he held until 2016, before being promoted to Assistant Professor of Neurology. These roles engaged him in teaching and research in the neurology domain, enabling him to share his knowledge with budding neuroscientists.
Positions at Boston Children's Hospital
Robin Kleiman worked at Boston Children's Hospital from 2013 to 2020. He held dual roles during this period: Research Associate in Neurology and Director of Preclinical Research at the Translational Neuroscience Center. His work here focused on translating basic neurological research into preclinical experiments, aiming to advance understanding and treatments of neurological conditions.
Education and Expertise
Robin Kleiman earned his Ph.D. in Neuroscience from the University of Virginia, where he studied from 1986 to 1993. He completed his undergraduate studies with a B.S. in Zoology from the University of Vermont from 1982 to 1986. His educational background laid a solid foundation for his extensive expertise in PDE biology, synaptic plasticity, and drug discovery.